Drugmakers have taken steps such as lowering insulin costs and waiving license restrictions on possible treatments in response to the COVID-19 pandemic. The companies have also cut staff and delayed mergers to protect themselves financially.
Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility
Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility
From our manufacturers, partners and pharmacies to physicians and their patients, our goal is to make life better for everyone we impact.